| Bioactivity | Glutamate-5-kinase-IN-2 (compound 54) is a potent glutamate-5-kinase (G5K) inhibitor with an MIC (minimum inhibitory concentration) of 4.2 µM. Glutamate-5-kinase-IN-2 shows G5K inhibition by promotes conformational changes at the L-glutamate binding site. Glutamate-5-kinase-IN-2 has the potential for the research of anti-TB agents[1]. |
| Target | G5K |
| Invitro | Glutamate-5-kinase-IN-2 (compound 54) (40 µM) inhibits G5K activity with an I0.5 of 33 µM at 10 mM concentration of L-Glu and ATP[1].Glutamate-5-kinase-IN-2 (5, 10, 20 µM) shows no relevant cytotoxicity in HepG2 cells[1]. |
| Name | Glutamate-5-kinase-IN-2 |
| Formula | C17H10ClFN2 |
| Molar Mass | 296.73 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Panciera M, et al. Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme. Eur J Med Chem. 2022 Mar 15;232:114206. |